Erich Mauff - Jushi Holdings Founder Consultant
| JUSHF Stock | USD 0.32 0.04 11.11% |
Insider
Erich Mauff is Founder Consultant of Jushi Holdings
| Age | 56 |
| Phone | 888 498 8842 |
| Web | https://www.jushico.com |
Jushi Holdings Management Efficiency
The company has return on total asset (ROA) of (0.0521) % which means that it has lost $0.0521 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3017) %, meaning that it generated substantial loss on money invested by shareholders. Jushi Holdings' management efficiency ratios could be used to measure how well Jushi Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| Elizabeth JD | ANI Pharmaceuticals | N/A | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| BComm BCom | Akanda Corp | 68 | |
| Eugene III | Biofrontera | 39 | |
| Sibyl Swift | cbdMD Inc | 43 | |
| Jeff Holm | Biofrontera | N/A | |
| Rami Levy | INC Research Holdings | 59 | |
| Tejinder Virk | Akanda Corp | 42 | |
| Raymond Coffman | cbdMD Inc | 62 | |
| John Weston | cbdMD Inc | N/A | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| Sandra Beaver | Evolus Inc | 46 | |
| CCFP DipSportMed | Evolus Inc | 60 | |
| OriMoni Mimon | INC Research Holdings | 36 | |
| BCom BAcc | Akanda Corp | 44 | |
| Hermann Lubbert | Biofrontera | 68 | |
| Amos Cohen | INC Research Holdings | 45 | |
| Matthew Coapman | cbdMD Inc | 48 | |
Management Performance
| Return On Equity | -0.3 | |||
| Return On Asset | -0.0521 |
Jushi Holdings Leadership Team
Elected by the shareholders, the Jushi Holdings' board of directors comprises two types of representatives: Jushi Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jushi. The board's role is to monitor Jushi Holdings' management team and ensure that shareholders' interests are well served. Jushi Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jushi Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tobi Lebowitz, Chief Sec | ||
| James Cacioppo, Chairman Founder | ||
| Nichole Upshaw, Chief Officer | ||
| Louis Barack, President, Founder | ||
| Michael Perlman, Ex Relations | ||
| Trenton Woloveck, Chief Director | ||
| James Cabral, Chief Exec | ||
| Erich Mauff, Founder Consultant | ||
| Leonardo GarciaBerg, Chief Officer | ||
| Ian Farrell, VP Compliance |
Jushi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Jushi Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.3 | |||
| Return On Asset | -0.0521 | |||
| Profit Margin | (0.18) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 634.2 M | |||
| Shares Outstanding | 195.78 M | |||
| Shares Owned By Insiders | 19.83 % | |||
| Shares Owned By Institutions | 0.90 % | |||
| Price To Book | 1.73 X | |||
| Price To Sales | 0.90 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Jushi OTC Stock
Jushi Holdings financial ratios help investors to determine whether Jushi OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jushi with respect to the benefits of owning Jushi Holdings security.